A stress test with a slight chance of MI or death... 😕
Do patients truly understand the risks we communicate?
European Hospital features discussion on medical risk communication across different cultures & systems.
Do patients truly understand the risks we communicate?
European Hospital features discussion on medical risk communication across different cultures & systems.
“Very rarely a chance of heart attack or death” – Wait, what?
Hospitalists frequently discuss the risks associated with tests, treatments, and/or surgical procedures with their patients. But is everyone in the clear on what a “slight risk of complications” actually means? A session on the meaning of risk to patients and how to effectively communicate risk was discussed at SHM Converge 2025, the annual meeting of the Society of Hospitalist Medicine held in Las Vegas in April.
healthcare-in-europe.com
Pure gold from Adam Rodman on overconfidence of reasoning models. Does this mirror incompetent + overconfident residents?
x.com/AdamRodmanMD/s... (yes, X, but worth your while)
x.com/AdamRodmanMD/s... (yes, X, but worth your while)
🌟 Amazing opportunity! 🌟
Our EU project partner @erasmusuni seeks Associate Prof in Health Economics & Modelling! 📈🏥 Join 100+ health economists in Rotterdam 🇳🇱
Check it out here and apply today:
www.academictransfer...
#HealthEconomics #HEOR #AcademicJobs
Our EU project partner @erasmusuni seeks Associate Prof in Health Economics & Modelling! 📈🏥 Join 100+ health economists in Rotterdam 🇳🇱
Check it out here and apply today:
www.academictransfer...
#HealthEconomics #HEOR #AcademicJobs
Associate professor (UHD) in Health Economics and Modelling (Fulltime/permanent)
We are seeking an experienced health economist with proven modelling and analytics skills to join our HTA department. The successful candidate will lead and collaborate on high-impact research projects, develop grant applications, supervise PhD and …
www.academictransfer.com
Bottom Line: Extended low-dose apixaban significantly reduces recurrent VTE in patients with provoked VTE + enduring risk factors, with low major bleeding risk. This will likely change practice and guidelines.
www.nejm.org/doi/ful...
8/8
www.nejm.org/doi/ful...
8/8
Apixaban for Extended Treatment of Provoked Venous Thromboembolism | NEJM
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients
who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant
enduring risk f...
www.nejm.org
Clinical Implications: The 10% recurrence rate in placebo group suggests "provoked" VTE with enduring risk factors may have similar recurrence risk to "unprovoked" VTE. Simple provoked vs unprovoked categorization may be insufficient for treatment decisions.
7/8
7/8
Study Population: Mean age 59.5 years, 57% female. Most common provoking factors: surgery (33.5%), immobility (31.3%), trauma (19.2%). Most common enduring risk factors: chronic inflammatory disease (52.2%), obesity BMI≥30 (48.2%), atherosclerotic CVD (29.3%).
6/8
6/8
Safety Events: Major bleeding: 0.3% (apixaban) vs 0% (placebo). Clinically relevant non-major bleeding: 4.8% vs 1.7% (HR 2.68, P=0.06). One major bleed was a 3mm subdural hematoma after horse fall - no hospitalization required.
5/8
5/8
Primary Results: Symptomatic recurrent VTE occurred in 1.3% (apixaban) vs 10.0% (placebo)
- an 87% relative risk reduction (HR 0.13, 95% CI 0.04-0.36, p<0.001)
Number needed to treat = 12
4/8
- an 87% relative risk reduction (HR 0.13, 95% CI 0.04-0.36, p<0.001)
Number needed to treat = 12
4/8
Study Design: HI-PRO was a randomized, double-blind, placebo-controlled trial.
600 patients with provoked VTE + ≥1 enduring risk factor received apixaban 2.5mg BID vs. placebo for 12 months after completing ≥3 months of initial anticoagulation.
3/8
600 patients with provoked VTE + ≥1 enduring risk factor received apixaban 2.5mg BID vs. placebo for 12 months after completing ≥3 months of initial anticoagulation.
3/8
Background: Current guidelines recommend 3-6 months of anticoagulation for provoked VTE (surgery, trauma, immobility).
What about patients with enduring risk factors like obesity, chronic lung disease, or autoimmune disorders?
2/8
What about patients with enduring risk factors like obesity, chronic lung disease, or autoimmune disorders?
2/8
🧵 HI-PRO trial from @escardio: low-dose apixaban _long-term_ for "provoked" VTE
This will likely be practice-changing: HI-PRO challenges the current practice re: anticoagulation duration for "provoked" VTE
1/8 📊
This will likely be practice-changing: HI-PRO challenges the current practice re: anticoagulation duration for "provoked" VTE
1/8 📊
6/7
🔍 Learn more about the projections (incl. brilliant viz) directly from the Guardian article:
www.theguardian.com/...
Thoughts?
🔍 Learn more about the projections (incl. brilliant viz) directly from the Guardian article:
www.theguardian.com/...
Thoughts?
Europe’s population crisis: see how your country compares – visualised
How anti-immigration politics across the EU clashes with demographic reality
www.theguardian.com
5/6
⚖️ Migration is one factor shaping Europe’s future. Employment rates, pension reform & healthcare capacity also matter. Some rural areas face depopulation, but newcomer resettlement projects show potential to revitalize communities.
⚖️ Migration is one factor shaping Europe’s future. Employment rates, pension reform & healthcare capacity also matter. Some rural areas face depopulation, but newcomer resettlement projects show potential to revitalize communities.
4/6
🏥 European health systems depend heavily on foreign-trained doctors. Norway, Ireland, Switzerland, UK & Sweden have 30-44% foreign-trained doctors.
🇳🇴 relies on Norwegians educated abroad due to limited domestic medical school slots.
🏥 European health systems depend heavily on foreign-trained doctors. Norway, Ireland, Switzerland, UK & Sweden have 30-44% foreign-trained doctors.
🇳🇴 relies on Norwegians educated abroad due to limited domestic medical school slots.
3/6
💸 Tax burdens are rising as pension & elderly care costs grow. These demographic trends will put greater fiscal pressure on governments & societies in decades ahead.
💸 Tax burdens are rising as pension & elderly care costs grow. These demographic trends will put greater fiscal pressure on governments & societies in decades ahead.
2/6
📉 Low birth rates drive native population decline. Without migration, the EU population could fall from 447M today to ~295M by 2100. The share of 65+ could rise from 21% to 36%, increasing care burdens & government spending.
📉 Low birth rates drive native population decline. Without migration, the EU population could fall from 447M today to ~295M by 2100. The share of 65+ could rise from 21% to 36%, increasing care burdens & government spending.
1/6
🌍 Europe faces a major demographic challenge. By 2100, the 🇪🇺’s population may shrink 6% with migration, but over 1/3 without it. Countries like Italy, Germany & France could face economic pressures from ageing populations & shrinking workforces.
#Demographics #Europe
🌍 Europe faces a major demographic challenge. By 2100, the 🇪🇺’s population may shrink 6% with migration, but over 1/3 without it. Countries like Italy, Germany & France could face economic pressures from ageing populations & shrinking workforces.
#Demographics #Europe
📢 PhD in Health Economics @ University Of Oslo! Fully paid 3yr position in MoPeK project on sustainable municipal health staffing. Join our dynamic research environment & contribute to real health policy change.
Apply by Sept 30!
#PhD #HealthEconomics
Apply by Sept 30!
#PhD #HealthEconomics
PhD stipendiat i helseøkonomi (284854) | Universitetet i Oslo
Stillingstittel: PhD stipendiat i helseøkonomi (284854), Arbeidsgiver: Universitetet i Oslo, Søknadsfrist: tirsdag 30. september 2025
www.jobbnorge.no
What authoritarianism looks like in science
RFK Jr demanded a vaccine study be retracted — the journal said no
Nature - In a rare move for a US public official, health secretary Robert F. Kennedy Jr called for a Danish paper finding no link between aluminium in vaccines and disease to be retracted.
www.nature.com
This conference has an intriguing format: the discussant summarizes the paper (circulated beforehand & assumed read) and then gives constructive feedback. The author then responds by answering questions and concerns. Then the audience serves as an additional sounding board
Overheard at the 44th Nordic Health Economists' Study Group 2025 in Oslo: "crouching tiger, hidden labor market"
- however, NHSEG now has one of their parallel sessions dedicated to economic evaluation!
1/2
- however, NHSEG now has one of their parallel sessions dedicated to economic evaluation!
1/2
Overheard at a economics conference: "crouching tiger, hidden labor market"
💡 We need systemic change. Academia belongs to humanity, not shareholders.
How to accomplish that? Not easy without tearing the whole system apart IMHO
Your thoughts?
How to accomplish that? Not easy without tearing the whole system apart IMHO
Your thoughts?
⚖️ Will universities face a dilemma in the future: hire more human researchers OR license AI tools from publishers?
🧑🏫 vs. 🤖?
Could fundamentally reshape academia?
And we haven't even touched how the research will look like - will it be all more, well, uniform?
🧑🏫 vs. 🤖?
Could fundamentally reshape academia?
And we haven't even touched how the research will look like - will it be all more, well, uniform?
🧩 These deals are PIECEMEAL - only some publishers, some content
Same could be true for the publisher's AI tools
AI models trained on incomplete literature will have systematic gaps & biases
Science needs complete knowledge, not cherry-picked data
Same could be true for the publisher's AI tools
AI models trained on incomplete literature will have systematic gaps & biases
Science needs complete knowledge, not cherry-picked data
🤖 cont'd
Springer Nature:
-Geppetto (in-house nonsense text detector)
-SnappShot: fraudulent images
Wiley:
-author-facing AI assistants
-Papermill Detection Service
-LLM detectors (the irony..)
Springer Nature:
-Geppetto (in-house nonsense text detector)
-SnappShot: fraudulent images
Wiley:
-author-facing AI assistants
-Papermill Detection Service
-LLM detectors (the irony..)
🤖 cont'd
Elsevier alone has at least 5 AI initiatives related to health/medicine:
-ScienceDirect AI
-Scopus AI
-Embase AI
-ClinicalKey AI
-SciBite: ontology-backed semantics/search, a chatbot built on top, promising traceability, explainability, and integration
Elsevier alone has at least 5 AI initiatives related to health/medicine:
-ScienceDirect AI
-Scopus AI
-Embase AI
-ClinicalKey AI
-SciBite: ontology-backed semantics/search, a chatbot built on top, promising traceability, explainability, and integration